Articles

‘Eureka moment’

City of Hope researchers identify possible cause of type 1 diabetes
Written byIlene Schneider
| 3 min read

DUARTE, Calif.—About 1.5 million Americans suffer from type 1 diabetes (T1D), previously known as juvenile diabetes, which results from the loss of insulin-producing cells in the pancreas. While the root cause of T1D was believed to be the immune system mistakenly identifying those insulin-secreting beta cells as a potential danger and, in turn, destroying them, an international team of researchers has found a mechanism in which stressed beta cells are actually causing the immune response that leads to T1D.

City of Hope’s Dr. Bart Roep, the Chan Soon-Shiong Shapiro Distinguished Chair in Diabetes and professor/founding chair of the Department of Diabetes Immunology, along with researchers from the Leiden University Medical Center in the Netherlands, reported the results in the journal Nature Medicine. The work was supported by the Dutch Diabetes Research Foundation, the DON Foundation and the JDRF.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A scientist in protective laboratory attire examines a sample under a microscope, surrounded by digital overlays of DNA strands, molecular structures, scientific symbols, and data graphics.
From automated experiments to AI-powered analysis, connected data, and smarter resource use, digital technologies are reshaping how scientists work — and what the laboratory itself can do.
A scientist in protective laboratory attire examines a sample under a microscope, surrounded by digital overlays of DNA strands, molecular structures, scientific symbols, and data graphics.
From automated experiments to AI-powered analysis, connected data, and smarter resource use, digital technologies are reshaping how scientists work — and what the laboratory itself can do.
Blue microscopic illustration of spherical cells with textured surfaces against a dark background.
Explore how longitudinal single-cell profiling of whole blood can reveal immune signatures associated with CAR T cell therapy-related neurotoxicity.